Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Aerovate Therapeutics, Inc. (AVTE)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 27,670,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Aerovate Therapeutics is a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. Co.'s initial focus is on improving AV-101, its dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. AV-101, delivered using a dry powder inhaler, is designed to provide lung concentrations at or above those observed with the oral dose while limiting systemic levels of the drug.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 198,525 283,422 343,887 1,083,676
Total Sell Value $5,199,454 $6,632,651 $7,649,183 $16,638,542
Total People Sold 6 7 7 8
Total Sell Transactions 25 38 50 111
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 225
  Page 5 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-05-02 4 AS $21.15 $14,657 D/D (693) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-05-01 4 AS $20.61 $309,089 D/D (15,000) 693     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-05-01 4 OE $2.14 $32,100 D/D 15,000 15,693     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2023-04-21 4 AS $19.50 $78,000 D/D (4,000) 1,960     -
   Gillies Hunter CHIEF MEDICAL OFFICER   •       –      –    2023-04-21 4 OE $1.74 $6,960 D/D 4,000 5,960     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-04-06 4 AS $18.17 $186,829 D/D (10,283) 0     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-04-06 4 OE $1.74 $21,041 D/D 10,283 10,283     -
   Niven Ralph CHIEF SCIENTIFIC OFFICER   •       –      –    2023-04-05 4 AS $17.91 $40,942 D/D (2,250) 1,609     -
   Niven Ralph CHIEF SCIENTIFIC OFFICER   •       –      –    2023-04-05 4 OE $1.74 $4,555 D/D 2,250 3,859     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-04-03 4 AS $19.16 $290,916 D/D (15,000) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-04-03 4 OE $2.14 $32,100 D/D 15,000 15,000     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-03-06 4 AS $23.71 $243,954 D/D (10,282) 0     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-03-06 4 OE $1.74 $21,039 D/D 10,282 10,282     -
   Niven Ralph CHIEF SCIENTIFIC OFFICER   •       –      –    2023-03-06 4 AS $23.73 $53,440 D/D (2,250) 1,609     -
   Niven Ralph CHIEF SCIENTIFIC OFFICER   •       –      –    2023-03-06 4 OE $1.74 $4,555 D/D 2,250 3,859     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-03-01 4 AS $22.71 $357,196 D/D (15,000) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-03-01 4 OE $2.14 $32,100 D/D 15,000 15,000     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-02-06 4 AS $24.52 $252,881 D/D (10,284) 0     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-02-06 4 OE $1.74 $21,043 D/D 10,284 10,284     -
   Niven Ralph CHIEF SCIENTIFIC OFFICER   •       –      –    2023-02-06 4 AS $24.27 $54,612 D/D (2,250) 1,609     -
   Niven Ralph CHIEF SCIENTIFIC OFFICER   •       –      –    2023-02-06 4 OE $1.74 $4,555 D/D 2,250 3,859     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-02-01 4 AS $22.52 $340,197 D/D (15,000) 0     -
   Noyes Timothy P CHIEF EXECUTIVE OFFICER   •       •      –    2023-02-01 4 OE $2.14 $32,100 D/D 15,000 15,000     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-01-06 4 AS $25.62 $267,203 D/D (10,284) 0     -
   Dake Benjamin T SEE REMARKS   •       –      –    2023-01-06 4 OE $1.74 $21,043 D/D 10,284 10,284     -
  225 Records found
  1  2  3  4  5  6  7  8  9   
  Page 5 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us